ENDO 2025
12 - 15 July 2025
Efficacy and safety of somapacitan in non-GHD adolescents with short stature: 26-week results from the REAL9 phase 3 study
Affiliations
View Details
Hide Details
Keywords
Get notified when materials for ENDO 2025 and future congresses become available:
Get notified when materials for ENDO 2025 and future congresses become available:
Success
We will notify you when new materials become available for ENDO 2025 and future congresses.
We will keep you updated in your inbox:
Almost Done